Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n°56

Posts Tagged ‘investor’

The Trade Desk to Host Investor Day In New York

Posted by fidest press agency su sabato, 9 febbraio 2019

Global advertising technology leader, The Trade Desk (Nasdaq:TTD), plans to host an investor day on March 6, 2019 at the NASDAQ Marketsite in New York City. Key members of The Trade Desk’s leadership team will host a series of presentations beginning at 1:00 PM Eastern Time until 5:00 PM Eastern time.The event, along with supporting materials, can be accessed live or via an archived replay through the Investor Relations section of the Company’s website at investors.thetradedesk.com. Space for the event is limited and, therefore, in-person attendance is by invitation only and advanced registration is required. Analysts and institutional investors interested in attending are encouraged to contact The Trade Desk Investor Relations at ir@thetradedesk.com.The Trade Desk™ is a technology company that empowers buyers of advertising. Through its self-service, cloud-based platform, ad buyers can create, manage, and optimize digital advertising campaigns across ad formats and devices. Integrations with major data, inventory, and publisher partners ensure maximum reach and decisioning capabilities, and enterprise APIs enable custom development on top of the platform. Headquartered in Ventura, CA, The Trade Desk has offices across North America, Europe, and Asia Pacific.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

2019 BIO CEO & Investor Conference

Posted by fidest press agency su sabato, 9 febbraio 2019

New York Monday, February 11, 2019 3:30pm ET Marriott Marquis (Gramercy room) 2019 BIO CEO & Investor Conference.VenatoRx is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. VenatoRx’s lead product, VNRX-5133, is an injectable broad-spectrum beta-lactamase inhibitor (BLI) that directly inhibits all four Ambler classes of beta-lactamases. In addition, VenatoRx has a broad pipeline of preclinical programs, including a broad-spectrum orally bioavailable BLI, a novel class of Penicillin-Binding Protein (PBP) inhibitors that are impervious to beta-lactamase-driven resistance, and novel antiviral agents. By http://www.venatorx.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Investor Advisory: Adobe Announces Webcast of Investor Conference Participation

Posted by fidest press agency su venerdì, 8 febbraio 2019

San Francisco, CA Wednesday, Feb. 13, 2019, 5 p.m. Eastern Time Mike Saviage, VP, Investor RelationsAudio of this presentation will be webcast live from Adobe’s Investor Relations website at http://www.adobe.com/ADBE. Conference presentation times are subject to change at the discretion of the conference host. An archive of the webcast will be available for a limited time.Adobe uses its website as a channel of distribution of material company information. Financial, product and other material information regarding Adobe is routinely posted on and accessible at http://www.adobe.com, http://www.adobe.com/ADBE and theblog.adobe.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Alnylam to Webcast Presentations at Upcoming February Investor Conferences

Posted by fidest press agency su giovedì, 7 febbraio 2019

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences:
21st Annual BIO CEO & Investor Conference on Monday, February 11, 2019 at 1:30 pm ET at the Marriott Marquis in New York City
8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 10:30 am ET at the Lotte New York Palace Hotel in New York City
A live audio webcast of each presentation will be available on the Investors section of the Company’s website, http://www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.
Alnylam (Nasdaq: ALNY) is leading the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to improve the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust discovery platform. ONPATTRO® (patisiran) lipid complex injection, available in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults, is Alnylam’s first U.S. FDA-approved RNAi therapeutic. In the EU, ONPATTRO is approved for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. Alnylam has a deep pipeline of investigational medicines, including three product candidates that are in late-stage development. Looking forward, Alnylam will continue to execute on its “Alnylam 2020” strategy of building a multi-product, commercial-stage biopharmaceutical company with a sustainable pipeline of RNAi-based medicines to address the needs of patients who have limited or inadequate treatment options. Alnylam employs over 1,000 people worldwide and is headquartered in Cambridge, MA.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

21st Annual BIO CEO & Investor Conference in New York

Posted by fidest press agency su sabato, 2 febbraio 2019

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that Stefan Weber, CEO, will present at the 21st Annual BIO CEO & Investor Conference in New York, NY on Monday, February 11, 2019 at 2:15 p.m. ET in the Hudson room (7th floor) at the New York Marriott Marquis.BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Sponsored by the Biotechnology Innovation Organization, the world’s largest biotech trade association, BIO CEO provides a forum where institutional investors, industry analysts and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s partner Zambon. US WorldMeds holds the commercialization rights in the USA. Meiji Seika has the rights to develop and commercialize the compound in Japan and other key Asian territories. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome and ralfinamide for patients with specific rare pain indications. Newron is also developing Evenamide as the potential first add-on therapy for the treatment of patients with positive symptoms of schizophrenia. For more information, please visit: http://www.newron.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Zayo Executives to Present at December Investor Conferences

Posted by fidest press agency su domenica, 2 dicembre 2018

Zayo Group Holdings, Inc. (NYSE: ZAYO) announced today that executives from the company will present at two investor conferences in December. The links to the live webcasts for the conferences will be made available through the Investor Relations section of the Company’s website at: http://investors.zayo.com.Dan Caruso, chairman and CEO, will present at the UBS Global Media and Communications Conference at the Grand Hyatt in New York on Tuesday, December 4, 2018. The presentation will be webcast live at 9:30 a.m. EST.Matt Steinfort, CFO, will present at the Barclays Global Technology, Media and Telecommunications Conference at The Palace Hotel in San Francisco on Thursday, December 6, 2018. The presentation will be webcast live at 11:30 a.m. PST.
Zayo Group Holdings, Inc. (NYSE: ZAYO) provides communications infrastructure solutions, including fiber and bandwidth connectivity, colocation and cloud infrastructure to the world’s leading businesses. Customers include wireless and wireline carriers, media and content companies and finance, healthcare and other large enterprises. Zayo’s 130,000-mile network in North America and Europe includes extensive metro connectivity to thousands of buildings and data centers. In addition to high-capacity dark fiber, wavelength, Ethernet and other connectivity solutions, Zayo offers colocation and cloud infrastructure in its carrier-neutral data centers. Zayo provides users with flexible, customized solutions and self-service through Tranzact, an innovative online platform for managing and purchasing bandwidth. For more information, visit zayo.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Media Alert: Rambus to Present at Credit Suisse and Barclays Investor Conferences

Posted by fidest press agency su giovedì, 22 novembre 2018

Rambus Inc. (Nasdaq: RMBS) announced today that Luc Seraphin, chief executive officer, and Rahul Mathur, chief financial officer, will present at two upcoming investor events.
Credit Suisse 22nd Annual Technology, Media and Telecom Conference in Scottsdale, AZ on Wednesday, November 28, 2018 at 10:00 a.m. MT.
Barclays 2018 Global Technology, Media and Telecommunications Conference in San Francisco, CA on Wednesday, December 5, 2018 at 2:30 p.m. PT.
The presentations will be available through a webcast which can be accessed on the Rambus Investor Relations website at investor.rambus.com. A replay of each presentation will also be available on the website following the events.
Dedicated to making data faster and safer, Rambus creates innovative hardware, software and services that drive technology advancements from the data center to the mobile edge. Our architecture licenses, IP cores, chips, software, and services span memory and interfaces, security, and emerging technologies to positively impact the modern world. We collaborate with the industry, partnering with leading chip and system designers, foundries, and service providers. Integrated into tens of billions of devices and systems, our products and technologies power and secure diverse applications, including Big Data, Internet of Things (IoT) security, mobile payments, and smart ticketing. For more information, visit rambus.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Hanger to Present at Upcoming Investor Conferences

Posted by fidest press agency su domenica, 18 novembre 2018

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that management will participate in presentations and meetings with institutional investors at the following conferences:
The Credit Suisse 27th Annual Healthcare Conference, being held November 12-15 at The Phoenician in Scottsdale, Arizona. The investor presentation is scheduled for Thursday, November 15, 2018, beginning at 10:35 a.m. Eastern time. The presentation will be available via webcast on the investor relations section of the Company’s website, http://www.investor.hanger.com, and a replay will be available for 90 days.The Company will present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference, to be held at the Boca Raton Resort and Club, Boca Raton, Florida. The investor presentation is scheduled for Wednesday, December 5, 2018, beginning at 7:30 a.m. Eastern time. The presentation and replay will be available via webcast, per the information above.
The Company will also present at the CJS 19th Annual Investor Conference to be held Wednesday, January 9, 2019, at the Four Seasons Hotel in New York City. The presentation time has not yet been scheduled.
About Hanger, Inc. – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger’s Patient Care segment is the largest owner and operator of O&P patient care clinics with approximately 800 patient care locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With over 150 years of clinical excellence and innovation, Hanger’s vision is to lead the orthotic & prosthetic markets by providing superior patient care, outcomes, services and value. For more information on Hanger, visit http://www.hanger.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Hanger to Present at Upcoming Investor Conferences

Posted by fidest press agency su sabato, 17 novembre 2018

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that management will participate in presentations and meetings with institutional investors at the following conferences:
The Credit Suisse 27th Annual Healthcare Conference, being held November 12-15 at The Phoenician in Scottsdale, Arizona. The investor presentation is scheduled for Thursday, November 15, 2018, beginning at 10:35 a.m. Eastern time. The presentation will be available via webcast on the investor relations section of the Company’s website, http://www.investor.hanger.com, and a replay will be available for 90 days.The Company will present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference, to be held at the Boca Raton Resort and Club, Boca Raton, Florida. The investor presentation is scheduled for Wednesday, December 5, 2018, beginning at 7:30 a.m. Eastern time. The presentation and replay will be available via webcast, per the information above.
The Company will also present at the CJS 19th Annual Investor Conference to be held Wednesday, January 9, 2019, at the Four Seasons Hotel in New York City. The presentation time has not yet been scheduled.
About Hanger, Inc. – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger’s Patient Care segment is the largest owner and operator of O&P patient care clinics with approximately 800 patient care locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With over 150 years of clinical excellence and innovation, Hanger’s vision is to lead the orthotic & prosthetic markets by providing superior patient care, outcomes, services and value. For more information on Hanger, visit http://www.hanger.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Zendesk To Present At Upcoming Investor Conferences

Posted by fidest press agency su venerdì, 9 novembre 2018

Marc Cabi, Vice President of Strategy and Head of Investor Relations, will present at the UBS Global Technology Conference in San Francisco, California on Wednesday, November 14, 2018. Zendesk’s presentation is scheduled for 8:45 a.m., Pacific Time.
Tom Keiser, Chief Operating Officer, will present at the Wells Fargo Tech Summit in Park City, Utah on Tuesday, December 4, 2018. Zendesk’s presentation is scheduled for 2:20 p.m., Mountain Time.A live webcast of each presentation will be accessible by visiting Zendesk’s investor website at investor.zendesk.com. An archived version will be available for six months.
The best customer experiences are built with Zendesk. Zendesk’s powerful and flexible customer service and engagement platform scales to meet the needs of any business, from startups and small businesses to growth companies and enterprises. Zendesk serves businesses across a multitude of industries, with more than 125,000 paid customer accounts offering service and support in more than 30 languages. Headquartered in San Francisco, Zendesk operates worldwide with 16 offices in North America, Europe, Asia, Australia, and South America. Learn more at http://www.zendesk.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Novocure and Zai Lab to Host Investor Event

Posted by fidest press agency su venerdì, 9 novembre 2018

Novocure (NASDAQ: NVCR) announced today that it will host an investor event with Zai Lab on Nov. 14, 2018, in Shanghai, China. William Doyle, Novocure’s Executive Chairman, Dr. Samantha Du, Zai Lab’s CEO, and Tao Fu, Zai Lab’s President and Chief Operating Officer, will review the strategic collaboration for Tumor Treating Fields in Greater China and address questions from the audience. The investor event will be held in conjunction with the BioCentury-BayHelix China Healthcare Summit 2018 and will begin at 2:30 p.m. China Time.
Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and mesothelioma.
Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The Company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China’s pharmaceutical market and global unmet medical needs.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Zymeworks to Present at Upcoming Investor Conferences

Posted by fidest press agency su venerdì, 9 novembre 2018

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming Stifel 2018 Healthcare Conference taking place November 13-14, 2018 in New York, NY and at the Jefferies 2018 London Healthcare Conference taking place November 14-15, 2018 in London, England.
The Company will provide a corporate update at the Stifel Healthcare Conference on Tuesday, November 13, 2018 at 8:00 a.m. ET and at the Jefferies Healthcare Conference on Wednesday, November 14, 2018 at 2:40 p.m. GMT (9:40 a.m. ET).
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics. Zymeworks’ suite of complementary therapeutic platforms and its fully-integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly-differentiated product candidates. Zymeworks’ lead product candidate, ZW25, is a novel bispecific antibody currently being evaluated in an adaptive Phase 1 clinical trial. Zymeworks is also advancing a deep pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. In addition to Zymeworks’ wholly-owned pipeline, its therapeutic platforms have been further leveraged through multiple strategic partnerships with global biopharmaceutical companies.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Policy Certainty a key focus at SA Tomorrow Investor Conference

Posted by fidest press agency su lunedì, 5 novembre 2018

The Johannesburg Stock Exchange took part in the annual SA Tomorrow Investor Conference (“SA Tomorrow”) that kicked off on Thursday, 01 November in New York. Along with a South African delegation that included the newly appointed Minister of Finance, Tito Mboweni, South African Reserve Bank Governor, Lesetja Kganyago, cabinet ministers and members of the business community, the conference set out to boost investor confidence in the region.Now in its sixth year, “SA Tomorrow” is an investor roadshow aimed at attracting new investment opportunities to the country and creating a platform to discuss solutions to South Africa’s current challenges.Following closely on the minister of finance’s recent Medium-Term Budget Policy Statement (MTBPS), the conference focused primarily on the creation of an environment supportive of inclusive growth as South Africa battles a shrinking economy. Pressing policy and regulation issues also featured prominently with the concerns around the 3rd iteration of the Mining Charter, expropriation of land without compensation and the restructuring of state owned enterprises.“We welcome President Cyril Ramaphosa’s recently announced economic stimulus package. While we acknowledge that this is an important stepping stone to revive Africa’s most industrialised economy, we believe that implementation is what will unlock the country’s full potential. Naturally this needs to be coupled with a legislative and regulatory environment that is more business and investor friendly, something the current political leadership is keenly aware of,” says JSE chairman, Nonkululeko Nyembezi.
The various plenary sessions and speeches echoed sentiments delivered by President Cyril Ramaphosa’s recent trip to the United States and the local investor summit held last week.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PCM Announces Participation in Sidoti & Company Fall 2018 Investor Conference

Posted by fidest press agency su martedì, 11 settembre 2018

PCM, Inc. (NASDAQ: PCMI), a leading technology solutions provider, today announced that Brandon LaVerne, Chief Financial Officer of PCM, Inc., will participate in the Sidoti & Company Fall 2018 Investor Conference. The conference will be held at The Grand Hyatt located at 109 East 42nd Street in New York, NY. The Company will present at 2:05 PM Eastern on Thursday, September 27, 2018 in the in the Winter Garden room and will conduct one-on-one meetings that day.
A live webcast of the group presentations will be available at the PCM, Inc. investor relations website at investor.pcm.com. This webcast will be archived for 90 days following the live presentations.
PCM, Inc., through its wholly-owned subsidiaries, is a leading multi-vendor provider of technology solutions, including hardware, software and services to small, medium and enterprise businesses, state, local and federal governments and educational institutions across the United States, Canada and the UK. We generated net sales of $2.2 billion in the twelve months ended June 30, 2018.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

RingCentral to Participate in Upcoming Investor Conferences

Posted by fidest press agency su lunedì, 3 settembre 2018

RingCentral, Inc. (NYSE:RNG), a leading provider of global enterprise cloud communications and collaboration solutions, today announced that the company will be participating in the following investor events. David Sipes, Chief Operating Officer will be participating at:
Dougherty & Company 3rd Annual Institutional Investor Conference in Minneapolis, MN, on Thursday, September 6, 2018.
Vlad Shmunis, Founder, Chairman, and Chief Executive Officer, and Mitesh Dhruv, Chief Financial Officer will be presenting at:
Deutsche Bank Technology Conference, in Las Vegas, NV, on Wednesday, September 12, 2018 at 2:30 p.m. PT. Live webcast, as well as a replay, of the presentation will be accessible from the investor relations page of the RingCentral website at http://ir.ringcentral.com/.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Alibaba Group to Host Investor Day

Posted by fidest press agency su sabato, 1 settembre 2018

Alibaba Group Holding Limited (NYSE: BABA) today announced that it will host an Investor Day on September 17-18, 2018 China Time in Hangzhou, China. Speakers will include Jack Ma (Executive Chairman), Joe Tsai (Executive Vice Chairman), Daniel Zhang (Chief Executive Officer), Maggie Wu (Chief Financial Officer) and other members of our senior management team.Alibaba Group will provide a live webcast of key executives’ presentations on the Investor Day. The exact webcast time will be posted on the Investor Relations section of Alibaba Group’s corporate website at http://www.alibabagroup.com/en/ir/home before the Investor Day.The webcast will be available at the same website. A replay of the webcast and a summary of the day’s presentations will be available through the same link following the event, as well as at http://www.alizila.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

GreenSky, Inc. to Participate in Upcoming Investor Conferences

Posted by fidest press agency su lunedì, 27 agosto 2018

GreenSky, Inc. (“GreenSky” or the “Company”) (NASDAQ: GSKY), a leading financial technology company Powering Commerce at the Point of SaleSM, announced today that David Zalik, Chairman and Chief Executive Officer, Gerald Benjamin, Vice Chairman and Chief Administrative Officer, and Robert Partlow, Chief Financial Officer will participate in the following investor conferences:
Citi 2018 Global Technology Conference in New York on September 5th at 11:05 a.m. ET
Goldman Sachs Eighth Annual Financial Technology Conference in New York on September 6th at 8:00 a.m. ET Interested parties can listen to live webcasts of the presentations from the investor relations section of the Company’s website at http://www.greensky.com. A replay of the webcasts will be available after each event.
GreenSky, Inc. (NASDAQ: GSKY) is a leading technology company Powering Commerce at the Point of SaleSM for a growing ecosystem of merchants, consumers and banks. Our highly scalable, proprietary technology platform enables over 13,000 merchants to offer frictionless promotional payment options to consumers, driving increased sales volume and accelerated cash flow. Banks leverage GreenSky’s technology to provide loans to super-prime and prime consumers nationwide. Since our inception, approximately 1.9 million consumers have financed over $13 billion of commerce using our paperless, real time “apply and buy” technology. GreenSky is headquartered in Atlanta, Georgia. For more information, visit https://www.greensky.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Arcus Biosciences Announces Participation at Two Investor Conferences in September

Posted by fidest press agency su lunedì, 27 agosto 2018

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced the Company will be participating in the following upcoming investor conferences: Citi’s 13th Annual Biotech Conference in Boston on Wednesday, September 5, 2018. At 3:15 pm ET, Terry Rosen, Ph.D., Chief Executive Officer, will participate in a panel discussion entitled, “Targeted Therapies Oncology – Aiming for the Bull’s Eye.” Morgan Stanley 16th Annual Global Healthcare Conference in New York City on Thursday, September 13, 2018. At 4:40 pm ET, Terry Rosen, Ph.D., Chief Executive Officer, and Jennifer Jarrett, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat. Individuals may access the live audio webcast of the fireside chat by visiting the “Events & Presentations” section of the Company’s website at https://investors.arcusbio.com/investors/events-and-presentations. A replay of the webcast will be available for 30 days following the live event.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Zendesk to Present At Upcoming Investor Conference

Posted by fidest press agency su lunedì, 6 agosto 2018

Marc Cabi, Vice President of Strategy and Head of Investor Relations, will present at the Canaccord Genuity Growth Conference at the InterContinental Boston hotel in Boston, Massachusetts on Wednesday, August 8, 2018. Zendesk’s presentation is scheduled for 8:30 a.m., Eastern Time.A live webcast of the presentation will be accessible by visiting Zendesk’s investor website at investor.zendesk.com. An archived version will be available for six months. The best customer experiences are built with Zendesk. Zendesk’s powerful and flexible customer service and engagement platform scales to meet the needs of any business, from startups and small businesses to growth companies and enterprises. Zendesk serves businesses across a multitude of industries, with more than 125,000 paid customer accounts offering service and support in more than 30 languages. Headquartered in San Francisco, Zendesk operates worldwide with 15 offices in North America, Europe, Asia, Australia, and South America. Learn more at http://www.zendesk.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Principal to Host 2018 Investor Day on November 15, 2018 in New York City

Posted by fidest press agency su venerdì, 22 giugno 2018

Principal Financial Group® (Nasdaq: PFG) announced today that it will host it’s 2018 Investor Day on Thursday, November 15th, at the Nasdaq MarketSite in New York City. Dan Houston, chairman, president, and CEO of Principal® and Deanna Strable, CFO, will provide an update on the company. We will also feature two panel discussions with members of our leadership team: one on our digital investments and a second on future opportunities in our businesses.Additional information will be provided closer to the date of the meeting. If you are a new investor or have questions, please contact investor-relations@principal.com.Principal helps people and companies around the world build, protect and advance their financial well-being through retirement, insurance and asset management solutions that fit their lives. Our employees are passionate about helping clients of all income and portfolio sizes achieve their goals – offering innovative ideas, investment expertise and real-life solutions to make financial progress possible. To find out more, visit us at principal.com. Principal, Principal and symbol design and Principal Financial Group are trademarks and service marks of Principal Financial Services, Inc., a member of the Principal Financial Group.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »